You are here
Covid: New research suggests Novovax NVX-CoV2373 booster vaccine is effective against SARS-CoV-2 Omicron subvariants
Primary tabs
Covid: New research suggests Novovax NVX-CoV2373 booster vaccine is effective against SARS-CoV-2 Omicron subvariants
Tue, 2022-11-01 09:51 — mike kraft New research suggests booster dose of Novovax NVX-CoV2373 vaccine is effective against SARS-CoV-2 Omicron subvariants A new study evaluated the neutralizing antibody titers against the SARS-CoV-2 Omicron variant and its sub-lineages after two and three doses of the Novovax protein nanoparticle vaccine NVX-CoV2373. News-Medical.net
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments